Haiqi Lu

1.1k total citations
23 papers, 892 citations indexed

About

Haiqi Lu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Haiqi Lu has authored 23 papers receiving a total of 892 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Haiqi Lu's work include Epigenetics and DNA Methylation (7 papers), MicroRNA in disease regulation (4 papers) and Histone Deacetylase Inhibitors Research (4 papers). Haiqi Lu is often cited by papers focused on Epigenetics and DNA Methylation (7 papers), MicroRNA in disease regulation (4 papers) and Histone Deacetylase Inhibitors Research (4 papers). Haiqi Lu collaborates with scholars based in China, United States and Germany. Haiqi Lu's co-authors include Xian Wang, Hongchuan Jin, Huiyin Lan, Lifeng Feng, Jie Sun, Leiming Liu, Guangliang Li, Xiaoying Lin, Jun Yu and Qi Shen and has published in prestigious journals such as FEBS Letters, American Journal Of Pathology and Autophagy.

In The Last Decade

Haiqi Lu

21 papers receiving 883 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Haiqi Lu China	16	638	423	142	115	78	23	892
Takashi Morizono Japan	11	458 0.7×	299 0.7×	95 0.7×	53 0.5×	188 2.4×	15	777
Ya‐Sian Chang Taiwan	21	700 1.1×	388 0.9×	50 0.4×	251 2.2×	77 1.0×	71	1.2k
Daniela Cimino Italy	13	944 1.5×	702 1.7×	29 0.2×	147 1.3×	102 1.3×	16	1.2k
Akihisa Suzuki Japan	17	463 0.7×	156 0.4×	67 0.5×	192 1.7×	114 1.5×	28	834
Agnieszka Piekiełko‐Witkowska Poland	20	831 1.3×	380 0.9×	39 0.3×	124 1.1×	69 0.9×	51	1.1k
Hongwei Li China	18	971 1.5×	888 2.1×	82 0.6×	118 1.0×	18 0.2×	50	1.2k
Chao Cai China	21	749 1.2×	431 1.0×	49 0.3×	149 1.3×	43 0.6×	43	1.0k
B.J.C. van den Bosch Netherlands	14	729 1.1×	186 0.4×	32 0.2×	109 0.9×	152 1.9×	29	1.1k
Fenghua Guo China	14	367 0.6×	248 0.6×	41 0.3×	104 0.9×	41 0.5×	31	667

Countries citing papers authored by Haiqi Lu

Since Specialization

Citations

This map shows the geographic impact of Haiqi Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haiqi Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haiqi Lu more than expected).

Fields of papers citing papers by Haiqi Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haiqi Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haiqi Lu. The network helps show where Haiqi Lu may publish in the future.

Co-authorship network of co-authors of Haiqi Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Haiqi Lu. A scholar is included among the top collaborators of Haiqi Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haiqi Lu. Haiqi Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Yufei, et al.. (2025). Circulating tumor cells in breast cancer bone metastasis: mechanisms, clinical relevance, and future directions. Cell Death Discovery. 12(1). 48–48.

Lu, Haiqi, Zhaohui Lu, Yufei Wang, et al.. (2025). APOBEC in breast cancer: a dual player in tumor evolution and therapeutic response. Frontiers in Molecular Biosciences. 12. 1604313–1604313.

Wang, Yufei, et al.. (2024). Targeted therapeutic strategies for Nectin-4 in breast cancer: Recent advances and future prospects. The Breast. 79. 103838–103838. 4 indexed citations

Wang, Zhuo, Haiqi Lu, Yiming Zhong, et al.. (2024). Impaired cyclin D3 protein degradation contributes to trastuzumab resistance in HER2 positive breast cancer. Medical Oncology. 41(12). 305–305. 1 indexed citations

Zhang, Jianping, Zhuo Wang, Jili Hou, et al.. (2023). Targeting Trop-2 in cancer: Recent research progress and clinical application. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1878(4). 188902–188902. 41 indexed citations

Lu, Feng, et al.. (2021). Characteristics of Raindrop Size Distribution in Typhoon Nida (2016) before and after Landfall in Southern China from 2D Video Disdrometer Data. Advances in Meteorology. 2021. 1–14. 9 indexed citations

Zhang, Jianping, Guangliang Li, Lifeng Feng, Haiqi Lu, & Xian Wang. (2019). Krüppel-like factors in breast cancer: Function, regulation and clinical relevance. Biomedicine & Pharmacotherapy. 123. 109778–109778. 26 indexed citations

Liu, Leiming, Lingling Zhang, Lin Zhang, et al.. (2017). Hepatic Tmem30a Deficiency Causes Intrahepatic Cholestasis by Impairing Expression and Localization of Bile Salt Transporters. American Journal Of Pathology. 187(12). 2775–2787. 20 indexed citations

Lu, Haiqi, Guangliang Li, Chenyi Zhou, et al.. (2016). Regulation and role of post-translational modifications of enhancer of zeste homologue 2 in cancer development.. PubMed. 6(12). 2737–2754. 40 indexed citations

10.

Lan, Huiyin, Haiqi Lu, Xian Wang, & Hongchuan Jin. (2015). MicroRNAs as Potential Biomarkers in Cancer: Opportunities and Challenges. BioMed Research International. 2015. 1–17. 269 indexed citations

11.

Lu, Haiqi, Wei Jin, Jie Sun, et al.. (2014). New tumor suppressor CXXC finger protein 4 inactivates mitogen activated protein kinase signaling. FEBS Letters. 588(18). 3322–3326. 15 indexed citations

12.

Feng, Lifeng, Yanning Ma, Jie Sun, et al.. (2014). YY1-MIR372-SQSTM1 regulatory axis in autophagy. Autophagy. 10(8). 1442–1453. 62 indexed citations

13.

Shen, Qi, Qinghua Yao, Jie Sun, et al.. (2013). Downregulation of histone deacetylase 1 by microRNA‐520h contributes to the chemotherapeutic effect of doxorubicin. FEBS Letters. 588(1). 184–191. 26 indexed citations

14.

Sun, Jie, Haiqi Lu, Xian Wang, & Hongchuan Jin. (2013). MicroRNAs in Hepatocellular Carcinoma: Regulation, Function, and Clinical Implications. The Scientific World JOURNAL. 2013(1). 924206–924206. 68 indexed citations

15.

Lu, Haiqi, Guangliang Li, Leiming Liu, et al.. (2013). Regulation and function of mitophagy in development and cancer. Autophagy. 9(11). 1720–1736. 89 indexed citations

16.

Zhang, Shengjie, Tingting Jiang, Lifeng Feng, et al.. (2012). Yin Yang-1 suppresses differentiation of hepatocellular carcinoma cells through the downregulation of CCAAT/enhancer-binding protein alpha. Journal of Molecular Medicine. 90(9). 1069–1077. 31 indexed citations

17.

Feng, Lifeng, Min Pan, Jie Sun, et al.. (2012). Histone deacetylase 3 inhibits expression of PUMA in gastric cancer cells. Journal of Molecular Medicine. 91(1). 49–58. 35 indexed citations

18.

Zhang, Jing, et al.. (2011). Human Mammaglobin: A Superior Marker for Reverse-Transcriptase PCR in Detecting Circulating Tumor cells In Breast Cancer Patients. Biomarkers in Medicine. 5(2). 249–260. 16 indexed citations

19.

Wang, Xian, Xiaojia Wang, Jie Pan, et al.. (2010). Klotho is silenced through promoter hypermethylation in gastric cancer.. PubMed. 1(1). 111–119. 77 indexed citations

20.

Lu, Haiqi, et al.. (2009). Real-Time Fluorescent Quantitative Polymerase Chain Reaction Study of Polo-Like Kinase-1 in Pterygia. Journal of International Medical Research. 37(6). 1851–1858. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact